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Abstract
Objective: Episodic memory is impaired in Alzheimer’s disease (AD) dementia but thought to be relatively spared
in behavioral variant frontotemporal dementia (bvFTD). This view is challenged by evidence of memory impairment
in bvFTD. This study investigated differences in recognition memory performance between bvFTD and AD.
Method: We performed a retrospective analysis on the recognition trial of the Rey Auditory Verbal Learning Test in
patients with bvFTD (n= 85), AD (n= 55), and control participants (n= 59). Age- and education-adjusted between-
group analysis was performed on the total score and indices of discriminative ability and response bias. Correlations
between recognition and measures of memory, language, executive functioning, and construction were examined.
Results: Patients with AD had a significantly lower total recognition score than patients with bvFTD (control
28.8 ± 1.5; bvFTD 24.8 ± 4.5; AD 23.4 ± 3.6, p< .01). Both bvFTD and AD had worse discriminative ability than
controls (A’ control 0.96 ± 0.03; bvFTD 0.87 ± 0.03; AD 0.84 ± 0.10, p< .01), but there was no difference in response
bias (B” control 0.9 ± 0.2; bvFTD 1.6 ± 1.47; AD 1.4± 1.4, p< .01). AD had worse discriminability than bvFTD
(p< .05). Discriminability was associated with memory for both patient groups (median correlation coefficient r= .34)
and additionally associated with language (r= .31), but not executive functioning (r=−.03) in bvFTD. Response bias
was unrelated to other cognitive functions (r=−.02). Conclusions: Discriminability, but not response bias,
differentiated patients with bvFTD from AD. The presence of an impaired discrimination index suggests a “pure”
(recognition) memory deficit in bvFTD.
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INTRODUCTION
Behavioral variant frontotemporal dementia (bvFTD) and
Alzheimer’s disease (AD) are the two most common early
onset dementias (Ratvanali, Brayne, Dawson, & Hodges,
2002). In the clinical diagnostic phase, neuropsychological
assessment is used to detect impairments in cognitive func-
tioning and to differentiate between these two types of
dementia. The cognitive profile of bvFTD is characterized
by impaired executive functioning, social cognition, and
language [related to atrophy in frontal and temporal brain
areas (Rohrer & Rosen, 2013)], with relatively spared memory
and construction (Rascovsky et al., 2011). Theoretically, this
cognitive profile is markedly different from the profile of
AD, which is most commonly characterized by memory
deficits resulting from atrophy of the medial temporal lobe
(MTL; McKhann et al., 2011). In the last decade, this tradi-
tional view on the difference in cognitive profiles between
bvFTD and AD has been challenged by multiple reports
of (sometimes profound) memory impairments in patients
with bvFTD, even in early disease stages (Glosser, Gallo,
Clark, & Grossman, 2002; Hornberger, Piguet, Graham,
Nestor, & Hodges, 2010; Kramer et al., 2005; Pennington,
Hodges, & Hornberger, 2011; Ricci, Graef, Blundo, &
Miller, 2012). Likewise, patients with AD may present
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with executive dysfunctioning and/or significant “frontal”
behavioral symptoms (Ossenkoppele et al., 2015), making
the differentiation between bvFTD and AD in clinical
practice particularly challenging.
Systematic investigations of episodic memory functioning
in bvFTD are increasingly reported but show inconsistent
results (for review, see Poos, Jiskoot, Papma, van Swieten, &
van denBerg, 2018) that are only partly explained by differences
in testing procedures (verbal vs. visual memory tests; free vs.
cued recall) and variation in patient samples (e.g., inclusion
of nonprogressive “phenocopy” bvFTD patients, disease
duration, and heterogeneous clinical presentation). Several
studies report memory deficits in bvFTD (compared with
controls) that are equal in nature and extent to those found
in AD (e.g., Gregory, Orrell, Sahakian, & Hodges, 1997;
Hornberger et al., 2010; Pennington et al., 2011; Ricci
et al., 2012). Others, however, demonstrate relative sparing
of memory performance in bvFTD compared with AD
(e.g., Thompson, Stopford, Snowden, & Neary, 2005).
Free delayed recall measures appear to best discriminate
AD from bvFTD, with patients with AD performing worse
than bvFTD (Heidler-Gary & Hillis, 2007; Ricci et al., 2012),
although this difference is not found invariably (Hornberger
et al., 2010; Pennington et al., 2011).
Episodic memory impairment in bvFTD is commonly
viewed as a consequence of executive dysfunctioning
(i.e., poor organization, lack of efficient retrieval strate-
gies; Hornberger et al., 2010; Kramer et al., 2005) rather
than “pure” or primary amnesia. In contrast, Glosser et al.
(2002) showed that recall performance in bvFTD is not
enhanced by cueing (use of semantic clusters), indicating that
memory impairments in bvFTD are associated with primary
encoding deficits rather than suboptimal retrieval strategies.
In addition, recent studies show impaired memory perfor-
mance in patients with bvFTD even after controlling for exec-
utive load (Bertoux et al., 2014; Lemos, Duro, Simões, &
Santana, 2014). These findings are not surprising as several
brain structures important for memory performance, such as
the MTL (including the hippocampus and supporting struc-
tures) and brain regions that connect the MTL to prefrontal
areas (such as the fornix) (Rugg, Otten, & Henson, 2002)
are implicated not only in AD but in bvFTD as well
(Hornberger & Piguet, 2012). Indeed, deficits in delayed
recall in both AD and FTD rely not only on the MTL but
on the integrity of prefrontal areas as well (Frisch et al.,
2013; Irish, Piguet, Hodges, & Hornberger, 2014; Wong,
Flanagan, Savage, Hodges, & Hornberger, 2014).
The majority of studies investigating episodic memory
performance in bvFTD and AD focus on measures of
immediate or delayed (free) recall, most commonly with
verbal tests such as the Rey Auditory Verbal Learning
Test (RAVLT). Recognition memory is also routinely
assessed as part of these memory tests (both in clinical
practice and in scientific research) but has received much
less attention. This is unfortunate as recognition memory
paradigms may provide crucial information on memory
and executive processes aiding the differentiation between
AD and bvFTD. Recognition memory entails patients to
indicate whether a certain stimulus was previously encoun-
tered (“old”) or new. Patients with bvFTD tend to outperform
AD patients in recognition memory (Hornberger et al., 2010)
and sometimes even show no impairment compared to
control participants (Pasquier, Grymonprez, Lebert, Van der
Linden, 2001; Ricci et al., 2012). This finding may be attrib-
uted to the fact that cueing in recognition memory tasks ena-
bles patients with bvFTD to overcome retrieval problems
(at least to some extent), but the recognition deficits in AD
reflect true forgetting of the items. Under certain conditions,
patients with bvFTD may thus exhibit a greater ability to
discriminate “old” from “new” items than patients with
AD. Interestingly, differences in performance on recogni-
tion memory tasks between bvFTD and AD are not found
invariably (see, e.g., Glosser et al., 2002; Pennington et al.,
2011), suggesting that certain characteristics of the recog-
nition memory tasks (e.g., number of distractors, type of
cueing) may elicit a trend or bias toward a more liberal
(tendency to respond “yes” to any item that is presented)
or conservative (“no” tendency) response. Theoretically,
the ability to distinguish target words from distractor words
(“discriminability”) is indeed independent from the tendency
to favor “yes” or “no” responses when there is uncertainty
about the correct response (“response bias”) (Snodgrass &
Corwin, 1988). A person can thus exhibit a liberal response
bias when discriminative ability is either high or low (Kramer
et al., 2005). Patients with AD generally have a more liberal
response bias (Beth, Budson, Waring, & Ally, 2009; Budson,
Wolk, Chong, & Waring, 2006), resulting in an increase in
false positive responses (“yes” tendency) associated with
both prefrontal and (para)hippocampal areas (Budson et al.,
2006). Response bias in bvFTD has only been scarcely exam-
ined. Recent work by Flanagan et al. (2016) shows a higher
rate of false positive responses in both AD and bvFTD that
was most strongly correlated with measures of disinhibition
in the latter. As of yet, it remains unclear whether discrimi-
nability and response bias as such are valuable measures in
discriminating AD from bvFTD.
The aims of the present study were (1) to examine
differences in recognition memory performance on a widely
used verbal memory test (RAVLT) between patients with
bvFTD and AD, (2) to specifically compare measures of dis-
crimination and response bias between these groups, and
(3) to investigate associations between recognition memory
and other measures of memory, language, executive function-
ing within and between the groups, and disease severity.
METHOD
Participants
Retrospective data from 140 patients (85 bvFTD, 55 AD) and
59 control participants were included. Patients visited the
memory clinic of the Erasmus MC University Medical
Center between 2005 and 2018 for a standardized work-
up consisting of a neurological and neuropsychological
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assessment, laboratory testing (including lumbar puncture
in subsample), and brain imaging. Clinical diagnoses were
made in a multidisciplinary consensus meeting with an
experienced neurologist, geriatrician, neuropsychologist,
and radiologist. All patients with bvFTD met core clinical
diagnostic criteria for bvFTD with insidious onset, decline in
social behavior and personal conduct, emotional blunting, and
loss of insight reported by caregivers (Neary et al., 1998;
Rascovsky et al., 2011). Memory complaints and impaired
episodicmemory performancewere allowed for if the other core
diagnostic criteria were present. Nonprogressive (i.e., pheno-
copy bvFTD) patients were excluded as these patients present
with little or no memory dysfunction (Pennington et al.,
2011). Thirty-four patients were part of an ongoing epidemio-
logical study of Dutch pathologically confirmed genetic FTD
families [Dopper et al., 2014; progranulin (GRN) n= 12;
microtubule-associated protein tau (MAPT) n= 9; chromo-
some 9 open reading frame 72 (C9orf72) n= 13]. Patients
with AD met the NINCDS–ADRDA criteria for probable
AD (McKhann et al., 2011). Control participants were
included from two previous studies (n= 28, Papma et al.,
2014; n= 31, Steketee et al., 2016). These control partici-
pants reported no history of neurological (e.g., major stroke,
brain tumor, and epilepsy) or severe psychiatric disorder
(e.g., major depression, substance abuse) negatively affecting
cognition and a normal brain MRI. The study was approved
by the local medical ethics committee. The research was
completed in accordance with the Helsinki Declaration. All
participants gave written informed consent.
Neuropsychological Assessment
Neuropsychological assessment was performed as part of the
memory clinic work-up. Although the neuropsychological
test battery was standardized, adaptations were made for indi-
vidual patients according to type of symptoms and severity.
Neuropsychological tests that were performed by <50% of
participants were excluded from the analysis. Global cogni-
tive functioning was screened by means of the Mini-Mental
State Examination (MMSE; Folstein, Folstein, & McHugh,
1975) and the Frontal Assessment Battery (FAB; Dubois,
Slachevsky, Litvan, & Pillon, 2000).
Verbal learning and memory were assessed using the
Dutch version of the RAVLT (van der Elst, van Boxtel,
van Breukelen, & Jolles, 2005). The RAVLT is a supraspan
verbal learning test consisting of 5 learning trials of 15 words,
followed by a 20–30-min delayed free recall and a 30-word
delayed recognition trial including al 15 words from the
learning trials and 15 unrelated words. For the purpose of
the present analysis, the following parameters were derived
from the delayed recognition trial of the RAVLT:
1. Total score of delayed recognition (0–30)
2. Number of correctly recognized words in the recognition trial
(“hits,” 0–15)
3. Number of incorrectly recognized words in the recognition trial
(“false positives,” 0–15).
Level of performance on a yes–no recognition memory
test is reflected in the number of correct hits and false positive
errors. These data yield two measures of recognition memory
(adapted from signal detection theory): recognition discrim-
inability (the ability to distinguish target words from distrac-
tor words) and response bias (the tendency to favor “yes” or
“no” responses when there is uncertainty about the correct
response) (Kramer et al., 2005). Calculation of hits minus
false positives is a widely used and easily obtained measure
of discriminability, and the ratio between “yes” and “no”
answers entails a (crude) estimation of response bias.
Snodgrass and Corwin provide a more elaborate distribution-
free (nonparametric) model for calculating discriminability
(A’) and response bias (B”) that is specifically suitable for
a population of persons that may have poor discrimination
performance (e.g., persons with dementia) and can be applied
to non-normally distributed data (Snodgrass & Corwin, 1988).
Discrimination index A’ and response bias B” are estimated by
formulas (1) and (2):
A0 ¼ 0:5þ hits false alarmð Þ 1þ hits false alarmsð Þð Þ=
ð 4  hits 1 false alarmsð Þð Þ
(1)
B00 ¼ hits 1 hitsð Þ  false alarms 1 false alarmsð Þð Þ=
hits  1 hitsð Þ þ false alarms 1 false alarmsð Þð Þ
(2)
We chose to investigate both the simple and the more elabo-
rate measures of discriminability and response bias:
4. Discrimination index “hits minus false positives”
5. Discrimination index A’
6. Response bias yes/no ratio
7. Response bias index B”.
Other neuropsychological tests that were included in
the present analysis were the story recall subtest of the
Rivermead Behavioral Memory Test (RBMT; immediate
recall score 0–42, delayed recall % retained; Wilson,
Cockburn, & Baddeley, 1985), the Visual Association Test
(VAT; score 0–12; Lindeboom, Schmand, Tulner, Walstra, &
Jonker 2002), the Boston Naming Test (BNT; score 0–60;
Kaplan, Goodglass, &Weintraub, 1978), category fluency (ani-
mals, 1 min), letter fluency (letters D-A-T which are the Dutch
equivalent of F-A-S (Schmand, Groenink, & van den Dungen,
2008), modified Wisconsin Card Sorting Test (WCST; con-
cepts 0–6; Nelson, 1976), Trailmaking Test A and B (TMT;
time for card A and B, B/A ratio score; Corrigan &
Hinkeldey, 1987), Stroop Color–Word Test (time for card
I, II, and III, card III/II interference ratio score; Stroop,
1935), and Clock drawing test (score 0–14; after Royall,
Cordes, & Polk, 1998).
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Statistical analysis
RAVLT recognition memory scores were compared between
bvFTD, AD, and control participants with analysis of vari-
ance for normally distributed data or Kruskal–Wallis tests
for nonparametric data, adjusted for age, education, and time
since symptom onset. Post hoc pairwise comparisons (con-
trols vs. patients groups, bvFTD vs. AD) were analyzed with
Scheffe’s tests and, in case of nonparametric data, with
Mann–WhitneyU tests.Within the bvFTD group, differences
in RAVLT recognition memory between sporadic versus
genetic bvFTD and between patients with GRN, MAPT,
and C9orf72 mutations were also explored. Bivariate cor-
relation was used to assess the relation between RAVLT
recognition memory scores and other cognitive functions
(Pearson’s r for normally distributed data or Spearman’s
r for nonparametric data; adjusted for age and level of
education). Statistical analyses were performed using SPSS
Statistics 21.0 (IBM Corp., Armonk, NY, USA).
RESULTS
Table 1 shows the characteristics of the 199 participants.
Patients with bvFTDwere significantly younger than patients
with AD and controls [F(2,199)= 12.3, p< .001, η2= 0.11].
Both patient groups had a lower level of education compared
with the control participants [H(2)= 6.7, p< .05]. As expected,
patients with AD had the lowest MMSE score and the bvFTD
group had an intermediate position between the AD and con-
trol group [F(2,157)= 19.4, p< .001, η2= 0.20]. The FAB
was administered to 67/86 patients with bvFTD and 27/55
patients with AD and showed no significant difference
between groups [F(1,94)= 1.13, p= .79, η2= 0.001]. Time
since symptom onset (months) was shorter for bvFTD than
AD [t(136)=−2.69, p< .01]. As expected, both patient
groups showed significantly poorer performance than control
participants on all cognitive tests (Table 1). Compared with
bvFTD, the patients with AD had lower scores on measures
of memory (RAVLT, RBMT, and VAT), executive function-
ing (WCST, TMT, and Stroop), and construction (Clock
drawing) (Table 1).
Group Differences in RAVLT Recognition
Memory
With regard to performance on the RAVLT, patients with AD
had a significantly lower delayed recall and percentage sav-
ings score than the bvFTD group [F(1,140)= 7.16, p< .01,
η2= 0.05], but there was no difference between the two
patient groups in immediate recall [F(1,140)= 2.61, p= .11,
η2= 0.02) (see Table 1 and Figure 1). Table 2 shows the
differences in RAVLT recognition scores. Patients with
Table 1. Characteristics of the patients with bvFTD, AD, and the control group
bvFTD AD Control p Value for differencea
n 85 55 59
Age 62.0 ± 9.0 68.1 ± 7.2 67.0 ± 6.8 <.01 (bvFTD<AD= con)
Male sex (%) 51 (60) 32 (58) 35 (59) ns
Educationb, median (IQR) 5 (4–6) 5 (4–6) 5 (5–6) <.01 (bvFTD=AD< con)
MMSE 25.0 ± 4.5 22.7 ± 4.6 28.8 ± 1.1 <.01 (AD< bvFTD< con)
FABc 12.3 ± 4.0 12.6 ± 4.1 – ns
Months since symptom onset 30 ± 26 46 ± 42 – .02 (bvFTD<AD)
Cognitive tests
RAVLT total trial 1–5 (0–75) 28.3 ± 11.5 23.8 ± 9.0 44.6 ± 8.7 <.01 (AD= bvFTD< con)
RAVLT delayed recall (0–15) 4.8 ± 3.8 2.7 ± 2.7 9.3 ± 2.9 <.01 (AD< bvFTD< con)
RAVLT % savings (0–100)d 59 ± 36 40 ± 39 82 ± 17 <.01 (AD< bvFTD< con)
RBMT story immediate recall (0–42) 11.4 ± 10.3 7.5 ± 4.4 18.7 ± 5.6 <.01 (bvFTD=AD< con)
RBMT story % recall 56.9 ± 29.5 46.6 ± 34.7 79.1 ± 18.3 <.01 (bvFTD=AD< con)
Visual Association Test (0–12) 9.6 ± 3.3 5.6 ± 4.0 11.9 ± 0.3 <.01 (AD< bvFTD< con)
Boston Naming Test (0–60) 40.3 ± 12.4 41.5 ± 10.0 55.6 ± 3.2 <.01 (bvFTD=AD< con)
Category fluency 12.9 ± 5.1 12.2 ± 5.2 24.0 ± 5.1 <.01 (bvFTD=AD< con)
Letter fluency 17.4 ± 10.3 19.7 ± 10.8 38.6 ± 13.0 <.01 (bvFTD=AD< con)
mWCST concepts (0–6) 2.6 ± 1.8 1.7 ± 1.3 5.5 ± 1.1 <.01 (AD< bvFTD< con)
Trailmaking A 63.4 ± 39.8 94.6 ± 55.8 38.5 ± 17.3 <.01 (AD< bvFTD< con)
Trailmaking B 191.8 ± 92.4 269.4 ± 65.9 83.5 ± 34.6 <.01 (AD< bvFTD< con)
Stroop Color–Word card III 172.6 ± 101.6 227.3 ± 124.4 104.0 ± 22.9 <.01 (AD< bvFTD< con)
Clock drawing (0–14) 10.5 ± 2.2 8.8 ± 2.8 12.6 ± 1.1 <.01 (AD< bvFTD< con)
bvFTD, behavioral variant frontotemporal dementia; AD, Alzheimer’s disease; con, control participants; IQR, interquartile range; MMSE, Mini-Mental State
Examination; RAVLT, Rey Auditory Verbal Learning Test; RBMT, Rivermead Behavioral Memory Test; mWCST, modified Wisconsin Card Sorting Test.
a Between-group differences adjusted for age and level of education.
b Level of education according to Verhage (1964) (1= less than primary school, 7= university degree).
c Frontal Assessment Battery, available in 27 patients with AD.
d Defined as (delayed free recall/trial 5) *100.
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bvFTD had a lower total recognition score and hit rate than
the control participants and, in turn, the AD group per-
formed significantly worse than the patients with bvFTD
(total recognition score bvFTD vs. AD U = 1826, p < .05;
hits U = 1705, p < .01). Both patient groups had signifi-
cantly more false positives than controls, but there was
no difference in number of false positives between patients
with AD and bvFTD (bvFTD vs. AD U = 2746, p = .08).
For the discrimination indices (hits-FA and A’) both
patients with AD and bvFTD had worse discriminative
ability than controls (H = 62.8, p < .01) (Figure 2).
Patients with AD had a lower A’ than the bvFTD group,
but there was no difference in “hits minus false positives”
(discrimination index A’ U = 1789, p < .05; hits minus
false positives U = 1846, p = .054). An effect size calcula-
tion for the comparison of A’ between patients with bvFTD
and AD showed a medium effect size of 0.3–0.4, which
corresponds to a 72.6–78.7% overlap between the distribu-
tions (Zakzanis, 2001). With regard to the bias indices,
both dementia groups showed a higher yes–no ratio and
a lower B” than the controls (yes–no ratio H = 6.37,
p < .05; B” H = 9.02, p < .05) representing a (slightly
more) liberal response bias for the patients. There was
no difference in response bias between patients with
bvFTD and AD (yes–no ratio U = 2194, p = .54, d = 0.12).
For both AD and bvFTD, the standardized total recogni-
tion score was lower than the standardized delayed recall
score (z-scores standardized on the control group; AD
delayed recall −2.3 ± 0.9, total recognition −3.5 ± 2.4,
t(54) = 4.51, p < .01; bvFTD delayed recall −1.6 ± 1.3,
total recognition −2.6 ± 3.0, t(84) = 4.34, p < .01).
There were no differences between patients with sporadic
(n = 51) versus genetic (n = 34) bvFTD (see
Supplementary Table). In the subgroup of patient with a
known genetic mutation for bvFTD (n = 34) no differences
were observed in A’ or B’’(or any other measure of
RAVLT) between GRN and MAPT mutation carriers and
C9orf72 repeat expansion carriers (see Supplementary
Table). Repeating the analysis in those patients with
≤24 months of time since symptom onset versus >24
months yielded highly similar results (data not shown).
Correlations with Other Cognitive Functions and
Disease Severity
The results of the correlation analysis (Table 3) showed that
the discrimination indices (hits minus false positive and A’)
are associated with memory performance (RBMT, VAT) in
the AD and bvFTD groups. In the bvFTD group, additional
associations were found for measures of language (BNT,
semantic, and letter fluency). There were no significant asso-
ciations between the discrimination indices and measures of
executive functioning or construction in either patient group.
Similarly, there were no significant associations between
indices of response bias (yes/no ratio and B”) and any of
the other cognitive functions. Correlation analysis in the con-
trol group showed no clear patterns of associations, most
likely resulting from ceiling effects on the RAVLT recogni-
tion trial. With regard to disease severity, the correlation
analysis showed that “time since symptom onset”was signifi-
cantly correlated with delayed recognition (r=−.23) and
total hits (r=−.17) but not with A’ (r=−.16) or B” (.06).
Age was also not significantly associated with the recognition
variables (range r −.04 to −.15).
DISCUSSION
In the present study, we investigated differences recognition
memory between patients with bvFTD and AD. The main
results showed that both patients with bvFTD and AD had
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a significantly lower discriminability on the recognition trial
of the RAVLT than the control group. In turn, the AD group
had a significantly lower discriminability than patients with
bvFTD. Discriminative ability was mainly associated with
memory for both patient groups and additionally associated
with language but not executive functioning in bvFTD.
Although both patients with bvFTD and AD also had a
slightly more liberal response bias (“yes” tendency) than con-
trol participants, there was no difference in response bias
between the two patient groups. Response bias was also unre-
lated to other cognitive measures in our analysis.
These results corroborate the growing body of evidence
showing considerable episodic memory impairment in
bvFTD (Hornberger et al., 2010). Multiple previous studies
on delayed free recall and, to a lesser extent, immediate recall
show that episodic memory can even be similarly impaired in
bvFTD and AD (e.g., Gregory et al., 1997; Hornberger et al.,
2010; Pennington et al., 2011; Ricci et al., 2012). Indeed,
also in the present study, delayed recall performance was
impaired in both bvFTD and AD. Much less is known about
differences in recognition memory in differentiating AD from
bvFTD, which is surprising considering the high prevalence of
recognition memory paradigms in functional neuroimaging
studies in dementia (Clement, Belleville, & Mellah, 2010;
Papma et al., 2017) and the fact that recognition memory
is part of standard assessment of memory in clinical practice.
Our results partly confirm findings from a recent study by
Flanagan et al. (2016) showing a significantly increased false
positive rate for both patients with AD and bvFTD compared
to controls and no difference in the simple discrimination
index (“hits minus false alarms”) for patients with bvFTD
versus AD. In contrast, whereas Flanagan et al. showed that
discriminative ability was associated with executive functioning
(disinhibition), our results indicate an association with memory
but not executive functioning (in both AD and bvFTD). This
difference in involvement of executive functioning may be
due to differences in the type of executive process that was
measured (interference on the Stroop test vs. inhibition
of a semantically constrained response in the Hayling test;
Belleville, Rouleau, & Van der Linden, 2006). In the patients
with bvFTD, discriminability was associated with language
performance, possibly resulting from the verbal nature of
the RAVLT, and it also reflects the (sometimes striking) lan-
guage deficits that are present in bvFTD (i.e., naming, word
comprehension, and diminished propositional speech; Hardy
et al., 2016).
Response bias B”was not previously examined in bvFTD,
but Russo et al. (2017) report a significantly lower discrimi-
native ability and a liberal response bias in patients with AD,
which is highly similar to our findings in the AD group.
Table 2. Between-group differences in RAVLT recognition memory
bvFTD AD Control Statisticsa Group differences
Delayed recognition (0–30) 24.8 ± 4.5 23.4 ± 3.6 28.8 ± 1.5 H= 62.9, p< .01 AD< bvFTD< con
Total hits on recognition 13.2 ± 2.1 12.1 ± 2.6 14.1 ± 1.3 H= 28.8, p< .01 AD< bvFTD< con
False positives on recognition 3.4 ± 4.3 3.6 ± 3.0 0.3 ± 0.6 H= 56.2, p< .01 bvFTD=AD< con
Hits minus false positives 9.7 ± 4.5 8.4 ± 3.6 13.8 ± 1.5 H= 63.3, p< .01 bvFTD=AD< con
Discrimination index A’ 0.87 ± 0.12 0.84 ± 0.10 0.96 ± 0.03 H= 64.2, p< .01 AD< bvFTD< con
Yes/no ratio 1.6 ± 1.7 1.4 ± 1.4 0.9 ± 0.2 H= 6.4, p< .05 bvFTD=AD< con
Bias index B” −0.01 ± 0.43 −0.06 ± 0.42 0.15 ± 0.35 H= 9.0, p< .05 bvFTD=AD< con
RAVLT, Rey Auditory Verbal Learning Test; bvFTD, behavioral variant frontotemporal dementia; AD, Alzheimer’s disease; con, control participants.
a Analyses adjusted for age and level of education.
Table 3. Association between recognition memory indices and other cognitive functions in patients with bvFTD and AD
bvFTD AD
Hits – false positives A’ Yes/no ratio B” Hits – false positives A’ Yes/no ratio B”
RBMT story immediate 0.34* 0.31* −0.11 −0.05 0.40* 0.36þ −0.28 0.24
RBMT story % recall 0.24 0.22 −0.19 −0.02 0.51** 0.51** −0.09 −0.20
Visual Association Test 0.40** 0.40** −0.22 0.15 0.55** 0.53** −0.14 −0.15
Boston Naming Test 0.36** 0.38** −0.14 0.13 0.29* 0.27þ 0.16 −0.12
Category fluency 0.33** 0.36** −0.07 0.11 0.07 0.08 −0.02 −0.08
Letter fluency 0.25* 0.29** −0.11 0.05 0.15 0.11 −0.03 −0.23
mWCST concepts −0.07 −0.06 0.07 0.03 0.09 0.11 0.10 −0.19
Trailmaking B–A −0.01 −0.05 −0.07 −0.07 −0.17 −0.17 0.11 −0.17
Stroop III–II −0.03 −0.03 0.11 −0.20 −0.09þ −0.25 0.08 0.29þ
Clock drawing 0.10 0.13 −0.05 0.14 0.16 0.10 −0.23þ 0.19
bvFTD, behavioral variant frontotemporal dementia; AD, Alzheimer’s disease; con, control participants; A’, discriminability; B”, response bias.
Data are Spearman correlation coefficients adjusted for age and level of education. *p< .05, **p< .01, þp< .1.
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The lack of a difference in response bias between bvFTD
and AD found in our study appears counterintuitive, but the
(slightly) liberal response bias that was present in both patients
groups (but not in controls) is in line with previous findings in
patients with dementia (Beth et al., 2009). Possibly, the cause
of the liberal response bias is different between AD and
bvFTD (overendorsement of a yes response in an uncertain
situation vs. disinhibition/perseverative errors). In our view,
the presence of an impaired discrimination index A’ supports
the presence of a “true” memory deficit in bvFTD, corrobo-
rating results from previous studies (Hornberger et al., 2012).
Whereas patients with bvFTD outperformed patients with
AD in delayed recall, for both AD and bvFTD the recognition
score was significantly lower than the free recall score (rela-
tive to the control group), indicating the additional value of
the recognition memory paradigm. Post hoc analysis in the
groups of bvFTD patients showed no differences in discrim-
inability or response bias between GRN and MAPT mutation
carriers and C9orf72 repeat expansion carriers. This is sur-
prising as increasing evidence indicates mutation-specific
cognitive profiles in genetic bvFTD (e.g., Snowden et al.,
2015) and may have resulted from the modest sample size
in this subgroup analysis.
Strengths of the present study include the large and well-
defined patient samples, the use of the RAVLT as widely
used memory test, and involvement of both simple and elabo-
rate measures of discriminative ability and response bias.
Limitations include the lack of postmortem pathological con-
firmation in the patient groups, which is particularly problem-
atic in bvFTD (Klatka, Schiffer, & Powers, 1996; Varma
et al., 1999), albeit that 40% of the patients with bvFTD
had a known genetic mutation for bvFTD. Also, although
analyses were adjusted for time since symptom onset, the dis-
ease course is different between AD and bvFTDwhichmakes
it difficult to truly match the patient groups (as is reflected in
our study in lower age in bvFTD patients and lower MMSE
scores in AD patients). Moreover, in our sample, time since
symptom onset was shorter for bvFTD patients than for AD,
which reflects our role as an expertise center for FTD and
inclusion of a proportion of mutation carriers from known
FTD families in the Netherlands. One can hypothesize that
differences in memory performance in bvFTD and AD
change with disease progression and accompanying atrophy
of frontal and temporal brain areas. For example, it is hypoth-
esized that frontal/dysexecutive impairment in AD increases
as the disease progresses (Russo et al., 2017), which may
result in a larger (liberal) response bias and a potential larger
between-group difference. The mean age of the AD patients
was relatively young (68.1 ± 7.2 years) with an MMSE score
of 22.7 ± 4.6 indicating a substantial number of early-onset
cases and a relatively mild disease severity. Generalization
of our results to older patients and more severe disease stages
should therefore be performed with caution. We used the rec-
ognition trial of the RAVLT as it is one of themost commonly
used verbal episodic memory tests that is easily administered
and readily available in clinical practice. Our analyses were
thus constrained by the methodological limitations of such a
clinical tool, thereby also limiting generalizability of our
results. The paradigm of the California Verbal Learning
Test may be even better suited to examine the relative contri-
bution of memory and executive processes in these patient
groups as it allows for examination of (proactive and retroac-
tive) interference and cueing. It would also be valuable to
vary the conditions of the recognition memory paradigm
(number and type of distractor items) and see how this
influences discriminative ability and response bias in patients
with dementia. An important clinical implication that results
from our study is that although patients with AD show an
overall worse recognition memory performance, the presence
of a recognition memory deficit does not rule out bvFTD in
individual patients.
In sum, our results show a difference in recognition
memory performance between patients with bvFTD and
AD, particularly in discriminative ability, but not in response
bias. Discriminative ability was mainly associated with
memory for both patient groups and was additionally asso-
ciated with language but not executive functioning in
bvFTD. Response bias was unrelated to other cognitive
functions.
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